Get the Stockscreener App
0.3496
4.08%
0.0137
After Hours:
.35
0.0004
+0.11%
Cosmos Health Inc stock is traded at $0.3496, with a volume of 1.85M.
It is up +4.08% in the last 24 hours and up +37.85% over the past month.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
See More
Previous Close:
$0.3359
Open:
$0.3289
24h Volume:
1.85M
Relative Volume:
0.51
Market Cap:
$35.18M
Revenue:
$69.49M
Net Income/Loss:
$-21.13M
P/E Ratio:
-0.5387
EPS:
-0.649
Net Cash Flow:
$-14.46M
1W Performance:
+1.13%
1M Performance:
+37.85%
6M Performance:
+16.53%
1Y Performance:
-67.33%
1-Day Range:
$0.3289
$0.3554
1-Week Range:
$0.2936
$0.3554
52-Week Range:
$0.1616
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Name
Cosmos Health Inc
Sector
Industry
Phone
312-536-3102
Address
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Compare COSM vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.3496 | 35.18M | 69.49M | -21.13M | -14.46M | -0.649 |
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Cosmos Health Inc Stock (COSM) Latest News
Cosmos Health Reports Record $17.4 Million Q3 Revenue - Quiver Quantitative
Cosmos Health reports record ~$54.3M nine-month revenue; Q3 ~$17.4M, reaffirms >$90M 2026 outlook - TradingView
Cosmos Health Inc. Reaffirms Revenue Guidance for Fiscal 2026 - www.marketscreener.com
Cosmos Health sees revenue of about $54.3M for the nine months ended Sept 30 - TradingView
Cosmos Health Q3 revenue rises to record high on contract manufacturing - TradingView
Cosmos Health posts $54.3M in nine-month revenue, up 19% - StreetInsider
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Stock Titan
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Yahoo! Finance Canada
Cosmos Health Inc. (COSM) Posts Record 9M Revenue $54.3M, Reaffirms >$90M 2026 Outlook - TradingView
Cosmos Health Reports Record Preliminary Nine-Month Revenue of $54.3 Million, Up 19% Year Over Year; Delivers Record Q3 Revenue of $17.4 Million and Reaffirms 2026 Revenue Outlook of Over $90 Million - Morningstar
COSM Continues to Surge Revenue Growth - Yahoo Finance
Cosmos Health Inc (V67A.SG) stock price, news, quote and history - Yahoo Finance Australia
Cosmos Health Inc. Advanced Charts | COSM - Barron's
Cosmos Health stock fell 1.58 percent as brands expand globally - AD HOC NEWS
Cosmos Health Inc.Common Stock (Nasdaq:COSM) Stock Quote - FinancialContent
Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion - Morningstar
Price to sales ratio of Cosmos Health Inc – HAN:V67A - TradingView
Total liabilities of Cosmos Health Inc – HAN:V67A - TradingView
COSM Continues to Grow Business - Yahoo Finance
COSM Forecast — Price Target — Prediction for 2027 - TradingView
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - USA Today
Cosmos Health’s CosmoFarm unit reaches $15M quarterly revenue - Investing.com
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - marketscreener.com
Cosmos Health's CosmoFarm Reaches Record Annualized Revenue Above $60 Million, Up 4.3x Under Cosmos Health Ownership, as Robotics and AI Build Capacity to Support Over $100 Million in Annualized Revenue - Newswire.com
Robots and AI could let Cosmos Health's pharmacy distributor handle over $100 million in annual sales - Stock Titan
Cosmos Health Inc. (COSM) Says CosmoFarm Run-Rate Tops $60M; Adds Capacity Toward $100M+ - TradingView
Cosmos Health Inc. (COSM) Stock Price, News, Quote & History - ca.finance.yahoo.com
Cosmos Health Subsidiary Cana Laboratories Secures $20M Contract Manufacturing Pipeline (COSM) - GuruFocus
Cosmos Health’s Cana unit surpasses $20M CMO pipeline - Investing.com
An Athens factory's production pipeline exceeds 32.7 million units, with contracts up to 10 years. - Stock Titan
Cosmos Health's Contract Manufacturing Division Surpasses $20 Million in Implied Revenue and $18 Million in Implied Gross Profit Across Its Record 32.7 Million-Unit Production Pipeline - Yahoo Finance
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Cosmos Health Inc. (COSM) CMO Pipeline Implies $20M Revenue, $18M Gross Profit - TradingView
Why Did SOC, HTZ, COSM Stocks Tumble To 52-Week Lows? - Stocktwits
Cosmos Health Adds 5.2 Million Units in New Five-Year Agreements with Target Pharma; Orderbook Surges Past 32.7 Million Units, Up 31% Since June - Yahoo Finance
A weight-management capsule’s gel expands more than 100-fold. Cosmos Health proposes funding it without new shares. - Stock Titan
Cosmos Health Moves to Tokenize CCX0722 Intellectual Property in Innovative Non-Dilutive Structure, Eyes $562 Billion Weight-Management Market - Yahoo Finance
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com South Africa
Cosmos Health Secures Additional 2.5 Mln Units Under New Five-Year Contract Manufacturing Deal With Viofar - TradingView
COSM Looks 10.4% Undervalued on GF Value™ Amid Contract Manufact - GuruFocus
Cosmos Health Unit Enters 5-Year Contract Manufacturing Deal With Viofar Over Cardiovascular Medicine - Bitget
Cosmos Health subsidiary secures 5-year manufacturing deal - Investing.com
Cosmos Health subsidiary secures 5-year manufacturing deal By Investing.com - Investing.com UK
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - ACCESS Newswire
Cosmos Health Secures Additional 2.5 Million Units Under New Five-Year Contract Manufacturing Agreement with Viofar; Total Orderbook Surpasses 27.5 Million Units - Yahoo Finance
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - webull.com
COSM Looks 8.2% Undervalued on GF Value™ Amid Challenging Fundam - GuruFocus
Cosmos Health receives first orders for veterinary product line - Investing.com
Cosmos Health Launches C-ScrubVet in the UK, Advancing into the $69 Billion Global Animal Health Market - Fidelity Investments
Cosmos Health buyback reaches 5.11 million shares under $5 million program - scanx.trade
Cosmos Health Inc Stock (COSM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cosmos Health Inc Stock (COSM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jul 29 '26 |
Buy |
0.18 |
766,284 |
140,000 |
14,248,092 |
| Terzis Georgios | Chief Financial Officer |
Jun 16 '26 |
Buy |
0.25 |
168,135 |
42,000 |
2,235,398 |
| Siokas Grigorios | Chief Executive Officer |
Jun 11 '26 |
Buy |
0.21 |
218,447 |
45,000 |
13,481,808 |
| Siokas Grigorios | Chief Executive Officer |
Jun 10 '26 |
Buy |
0.23 |
701,447 |
160,000 |
13,263,361 |
| Siokas Grigorios | Chief Executive Officer |
Feb 12 '26 |
Buy |
0.37 |
388,532 |
145,000 |
8,861,914 |
| Siokas Grigorios | Chief Executive Officer |
Feb 11 '26 |
Buy |
0.41 |
291,262 |
120,000 |
8,473,382 |
| Siokas Grigorios | Chief Executive Officer |
Jan 23 '26 |
Buy |
0.50 |
90,325 |
45,000 |
8,182,120 |
| Siokas Grigorios | Chief Executive Officer |
Jan 20 '26 |
Buy |
0.50 |
353,321 |
175,000 |
8,091,795 |
| Siokas Grigorios | Chief Executive Officer |
Jan 14 '26 |
Buy |
0.45 |
493,495 |
220,000 |
7,738,474 |
| Siokas Grigorios | Chief Executive Officer |
Jan 12 '26 |
Buy |
0.50 |
113,185 |
57,000 |
7,244,979 |
8.76%
3.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):